Anticoagulation and Stroke

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.80, n.5, suppl.1, p.72-79, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In 2019, the American Heart Association did not recommend the emergent use of anticoagulation to prevent recurrence or progression of acute ischemic stroke. However, its indication in patients with extracranial artery intraluminal thrombus with artery-to-artery cerebral embolization must be analyzed. In this article, we will also discuss other indications of anticoagulation. This treatment could be indicated in patients with ischemic stroke caused by embolization from cervical artery dissection, catastrophic antiphospholipid antibodies syndrome (APS) and some cases of Covid 19. For secondary prevention, anticoagulation is recommended for Cardioembolic stroke such as nonvalvular atrial fibrillation and other cardiopathies, some patients with cervical artery dissection, stroke associated with cancer, and thrombophilia such as APS. The timing to restart anticoagulation after a large ischemic stroke or after a cerebral hemorrhagic transformation always represent a challenge. Even in patients with high risk of thromboembolism it should be delayed at least two weeks, ideal after four weeks.
Palavras-chave
Ischemic Stroke, Cerebral Infarction, Anticoagulants, Embolic Stroke, Atrial Fibrillation, Cerebral Hemorrhage
Referências
  1. Adams HP, 1998, JAMA-J AM MED ASSOC, V279, P1265, DOI 10.1001/jama.279.16.1265
  2. Agnelli G, 2020, NEW ENGL J MED, V382, P1599, DOI 10.1056/NEJMoa1915103
  3. Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2
  4. [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530
  5. Avezum A, 2015, CIRCULATION, V132, P624, DOI 10.1161/CIRCULATIONAHA.114.014807
  6. Becattini C, 2016, VASC PHARMACOL, V84, P15, DOI 10.1016/j.vph.2016.05.012
  7. Chiasakul T, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012877
  8. Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
  9. Diener HC, 2019, NEW ENGL J MED, V380, P1906, DOI 10.1056/NEJMoa1813959
  10. Engelter ST, 2007, STROKE, V38, P2605, DOI 10.1161/STROKEAHA.107.489666
  11. Fanola CL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008987
  12. Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280
  13. Fuster V, 1999, CIRCULATION, V99, P1132, DOI 10.1161/01.CIR.99.9.1132
  14. Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008
  15. Hart RG, 2018, NEW ENGL J MED, V378, P2191, DOI 10.1056/NEJMoa1802686
  16. HART RG, 1983, STROKE, V14, P688, DOI 10.1161/01.STR.14.5.688
  17. Hart RG, 2017, STROKE, V48, P867, DOI 10.1161/STROKEAHA.116.016414
  18. HORNIG CR, 1993, STROKE, V24, P465, DOI 10.1161/01.STR.24.3.465
  19. Jadhav AP, 2018, STROKE, V49, P2801, DOI 10.1161/STROKEAHA.118.021640
  20. January CT., 2014, J AM COLL CARDIOL, V64, P76, DOI [10.1016/j.jacc, 10.1016/j.jacc.2014.03.022, DOI 10.1016/J.JACC.2014.03.022]
  21. Kamel H, 2017, CIRC RES, V120, P514, DOI 10.1161/CIRCRESAHA.116.308407
  22. Kato ET, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003432
  23. Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210
  24. Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846
  25. Lansberg MG, 2012, CHEST, V141, pE601S, DOI 10.1378/chest.11-2302
  26. Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369
  27. Ma A, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105392
  28. Mac Grory B, 2019, CURR ATHEROSCLER REP, V21, DOI 10.1007/s11883-019-0790-x
  29. Mariani MV, 2021, J THROMB THROMBOLYS, V51, P419, DOI 10.1007/s11239-020-02304-3
  30. Ministerio da Saude, MORT DOENC CER
  31. Mokin M, 2013, J NEUROINTERV SURG, V5, P144, DOI 10.1136/neurintsurg-2011-010134
  32. Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735
  33. Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f
  34. Paciaroni M, 2015, STROKE, V46, P2175, DOI 10.1161/STROKEAHA.115.008891
  35. Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134
  36. Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211
  37. Sandercock P, 1997, LANCET, V349, P1569
  38. Shah S, 2018, BLOOD ADV, V2, P200, DOI 10.1182/bloodadvances.2017010694
  39. Silva GS, 2018, J STROKE MED, V1, P51, DOI [10.1177/2516608518776162, DOI 10.1177/2516608518776162]
  40. Tektonidou MG, 2019, ANN RHEUM DIS, V78, P1296, DOI 10.1136/annrheumdis-2019-215213
  41. Vellimana AK, 2013, J NEUROSURG, V118, P34, DOI 10.3171/2012.9.JNS12406
  42. Wang QS, 2012, STROKE, V43, P346, DOI 10.1161/STROKEAHA.111.628347
  43. Yaghi S, 2020, STROKE, V51, P2724, DOI 10.1161/STROKEAHA.120.028867